What's new

Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Status: Opinion

Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Status: Opinion

May 23, 2025 - 12:15
 0
Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Status: Opinion
Human medicines European public assessment report (EPAR): Emtricitabine / Tenofovir alafenamide Viatris, emtricitabine,tenofovir alafenamide, Status: Opinion
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Riulvy, tegomil fumara...

Next Article

Summary of opinion: Tevimbra, 22/05/2025 Positive

Related Posts

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0

Summary of opinion: NexGard Combo, 15/05/2025 Positive

Summary of opinion: NexGard Combo, 15/05/2025 Positive

May 16, 2025  0

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sodium, Date of authorisation: 15/09/2016, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0